Twin Focus Capital Partners, LLC Merck & Co., Inc. Transaction History

Twin Focus Capital Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $276,797 - $301,222	2,763 New	2,763 $301,000
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $39,968 - $43,563	368 Added 10.47%	3,883 $448,000
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $1,049 - $1,345	-12 Reduced 0.34%	3,515 $389,000
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $8,368 - $9,401	99 Added 2.89%	3,527 $304,000
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $9,350 - $10,599	112 Added 3.38%	3,428 $313,000
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $9,629 - $10,794	131 Added 4.11%	3,316 $272,000
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $230,211 - $288,369	3,185 New	3,185 $244,000
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $216,832 - $238,460	-3,025 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $212,687 - $235,254	3,025 New	3,025 $235,000
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $216,060 - $243,798	-2,785 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$76.08 - $82.93 $211,882 - $230,960	2,785 New	2,785 $234,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Twin Focus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Twin Focus Capital Partners, LLC with notifications on news.